ÂÜÀòÉç

Skip to main content

Treats Adults

Daniel E Soffer, MD

Cardiologist Interventional Cardiologist

Cardiologist, Interventional Cardiologist

Photo of Daniel E Soffer
(904) 383-1011

Research at a glance

Top areas of exploration

  • Platelet Aggregation Inhibitors , 14 publications
  • Clopidogrel , 11 publications
  • Ticagrelor , 10 publications
  • Platelet Aggregation , 8 publications

Research activity

37 publications

1,012 citations

Why is this important?

My publications

37 publications

2020

Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study.

Circulation

•

2020

Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing.

JACC. Basic to translational science

•

2020

Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study.

Journal of the American Heart Association

•

2020

Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.

Thrombosis and haemostasis

•

2019

Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study.

JACC. Basic to translational science

•